Liraglutide preserves renal function in overweight diabetic patients with stage 3 chronic kidney disease

Eur J Intern Med. 2017 Oct:44:e28-e29. doi: 10.1016/j.ejim.2017.07.020. Epub 2017 Jul 12.

Authors

María Dolores García de Lucas¹, Beatriz Aviles Bueno², Julián Olalla Sierra³

Affiliations

¹ Department of Internal Medicine, Hospital Costa del Sol, Marbella, Spain. Electronic address: gdelucaslola@gmail.com.
² Department of Nephrology, Hospital Costa del Sol, Marbella, Spain. Electronic address: avilesbb@hotmail.com.
³ Department of Internal Medicine, Hospital Costa del Sol, Marbella, Spain. Electronic address: julio.olalla@gmail.com.

PMID: 28711390
DOI: 10.1016/j.ejim.2017.07.020

No abstract available

Keywords: Albuminuria; Chronic kidney disease; HbA(1c); Hypoglycaemia; Liraglutide; Weight.

Publication types

Letter
Observational Study

MeSH terms

Aged
Body Mass Index
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy*
Female
Glomerular Filtration Rate / drug effects
Glycated Hemoglobin / analysis
Humans
Hypoglycemic Agents / administration & dosage*
Liraglutide / administration & dosage*
Male
Middle Aged
Overweight / drug therapy*
Renal Insufficiency, Chronic / physiopathology*
Retrospective Studies
Weight Loss / drug effects

Substances

Glycated Hemoglobin A
Hypoglycemic Agents
Liraglutide